Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cilia and flagella associated protein 100 (CFAP100) is a microtubule-associated protein that plays a key role in ciliary and flagellar motility, primarily by regulating the assembly and activity of the axonemal inner dynein arm[3][5]. It is also essential for the integrity of spindle pole structures during keratinocyte mitosis, working through the recruitment of tubulin tyrosine ligase-like protein 13 (TTLL13) to increase glutamylation of spindle microtubules[2]. CFAP100 depletion in mice leads to abnormal epidermal development, defective cell division, and impaired skin barrier function[2]. While mutations in the related family of cilia-associated proteins can lead to ciliopathies (such as inherited retinal dystrophy), direct links to human diseases for CFAP100 remain under investigation[2][3]. Currently, CFAP100 is not a recognized therapeutic target and has no established interacting drugs or biomarker role[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cilia and flagella associated protein 100 (CFAP100).